Japanese chemical industry news

• 

  24 December 2025

  Mitsui Chemicals, Idemitsu, Sumitomo Chemical Integrate PP and LLDPE Businesses

  The integration aims to enhance competitiveness, optimize production, and achieve cost savings, while focusing on sustainable, high-performance products in Japan's shrinking PO market.
• 

  23 December 2025

  Toray Unveils Energy-Efficient Bioreactor Technology

  New bioreactor tech cuts energy use by 80-90%, converts chemicals efficiently, and enhances safety. Customizable for diverse applications, it aims to lower costs and environmental impact.
• 

  22 December 2025

  Asahi Kasei Pharma Relocates R&D Hub to Shonan iPark

  The move aims to boost R&D capabilities, enhance open innovation, and attract talent by leveraging Shonan iPark's life-science ecosystem and advanced facilities.
• 

  19 December 2025

  ADNOC Secures $2 Billion Green Financing from K-SURE, Totaling $5 Billion in 18 Months

  ADNOC's $2B green financing supports lower-carbon projects, aligning with global standards. This enhances ADNOC's sustainable finance and strengthens ties with South Korea.
• 

  19 December 2025

  Idemitsu Kosan and Mitsui Chemicals to Consolidate Chiba Ethylene Complexes

  The companies will consolidate ethylene production at Mitsui's site by July 2027 to enhance competitiveness amid declining domestic demand and increased global competition.
• 

  18 December 2025

  Toray Unveils Cost-Effective Photo Definable Polyimide for Semiconductors

  New polyimide sheet enables efficient microfabrication, reduces costs, and minimizes thermal stress in semiconductor manufacturing.

• 

  18 December 2025

  Takeda's Zasocitinib Phase 3 Trials Show Promise for Plaque Psoriasis Treatment

  Zasocitinib met all primary and secondary endpoints in Phase 3 trials, showing potential for clear skin in plaque psoriasis with a consistent safety profile.
• 

  17 December 2025

  Merck's KEYTRUDA and Padcev Enhance Survival in Cisplatin-Eligible MIBC Patients

  KEYTRUDA and Padcev improve survival and response rates in MIBC patients, showing promise as perioperative treatment with consistent safety profiles.
• 

  17 December 2025

  Iberdrola Uses Seville-Made Solutions for German Offshore Wind Farm Protection

  Transition pieces at the Windanker wind farm are coated with a cork compound to endure marine conditions, with RTS evolving to offer marine protection solutions.
• 

  17 December 2025

  Mitsubishi Chemical's DURABIO Used in Honda's New EV

  DURABIO, a bio-based plastic, is used in Honda's N-ONE e: EV for its transparency, durability, and reduced VOC emissions, eliminating the need for a coating process.
• 

  15 December 2025

  Mitsubishi Chemical Expands Carbon Fiber Production in Japan and US

  Increasing demand in sports, aerospace, and hypercar sectors drives capacity boost for high-performance carbon fiber, doubling production by 2027.
• 

  11 December 2025

  Xeureka and UBE Partner for Oncology Drug Discovery

  The collaboration uses advanced computational methods to discover new small-molecule cancer drugs, with Xeureka receiving upfront and milestone payments.
• 

  11 December 2025

  Roche Secures CE Mark for Broadest Automated Mass Spectrometry IVD Menu

  Roche's automated mass spectrometry platform now offers 39 tests, enhancing lab efficiency and supporting faster, precise diagnoses, including antibiotic monitoring.
• 

  10 December 2025

  Toray Unveils Antistatic ABS Resin for Electronics

  New ABS resin reduces static, minimizing damage in semiconductor manufacturing. Offers improved durability, appearance, and color flexibility. Samples available next fiscal year.
• 

  8 December 2025

  Boehringer Ingelheim's JASCAYD® Approved in China for Progressive Pulmonary Fibrosis

  JASCAYD® (nerandomilast) gains approval in China for progressive pulmonary fibrosis, offering a new treatment option after five years, based on successful Phase III trials.
• 

  8 December 2025

  AGC Exits Specialty Glass for Chemical Strengthening

  AGC will cease specialty glass production by Q3 2026 due to declining performance. No change to the 2025 financial forecast despite exit costs.
• 

  7 December 2025

  Toray Develops Technology for 95% Lithium Recovery from Batteries

  New nanofiltration membrane efficiently recovers lithium from used batteries, enhancing recycling and supporting closed-loop systems for electrified vehicles.
• 

  6 December 2025

  Protagonist and Takeda: Rusfertide's Long-Term Efficacy in Polycythemia Vera

  Rusfertide shows sustained hematocrit control and reduced phlebotomy need in polycythemia vera over 52 weeks, with a consistent safety profile.
• 

  5 December 2025

  Sumisho Realty Management Receives Business Improvement Order

  SRM received a business improvement order for compliance issues. Measures are underway to prevent recurrence and strengthen internal controls. Impact on financial results is expected to be limited.
• 

  5 December 2025

  Iberdrola Completes Monopile Installation at Windanker Offshore Wind Farm

  The Windanker offshore wind farm's 21 monopile foundations are installed. The project is on track to be operational by 2026, expanding Baltic Sea capacity to over 1,100 MW.
• 

  5 December 2025

  Asahi Kasei to End HMD Production for Long-Term Profitability

  HMD production will end by April 2027, reallocating resources to key growth areas. Employee roles will be reassigned, with minimal impact on overall performance.
• 

  2 December 2025

  Asahi Kasei Divests Daramic Lead Battery Separator Business

  The divestiture aligns resources with growth areas like electronics and lithium-ion battery separators, enhancing Asahi Kasei's focus on high-potential initiatives and capital efficiency.
• 

  2 December 2025

  Johnson & Johnson's IMAAVY® (nipocalimab) Approved by European Commission for Generalised Myasthenia Gravis

  IMAAVY® (nipocalimab) gains EU approval for gMG, showing sustained disease control in adults and adolescents, with consistent safety and tolerability.
• 

  2 December 2025

  TotalEnergies and Partners Develop e-NG Project in Nebraska

  The Live Oak project aims to produce e-NG in Nebraska, targeting 250 MW electrolysis and 75 ktpa methanation, with operations by 2030, exporting to Japan for carbon-neutral goals.
• 

  2 December 2025

  Asahi Kasei Sells Daramic Lead Battery Separator Business

  The divestiture aligns resources for growth in electronics and lithium-ion battery separators, focusing on North America, Japan, and Korea, under a strategic management plan.
• 

  28 November 2025

  Asahi Kasei's Oita Plant Earns EcoVadis Platinum for Sustainability

  The Oita Plant received its second EcoVadis Platinum Medal for top 1% sustainability, excelling in Environment and Labor & Human Rights.
• 

  28 November 2025

  Sendai Biomass Power Plant by Sumitomo and Partners Begins Operations

  The Sendai Biomass Plant, with 112 MW output, uses certified wood fuels to support carbon neutrality and renewable energy in Tohoku, Japan.
• 

  27 November 2025

  Braskem and Katoen Natie Launch Singapore Warehouse Project

  The warehouse in Singapore will enhance logistics for bio-based products in Southeast Asia, optimizing supply chain performance and reducing transport routes.
• 

  26 November 2025

  Toray Unveils New Bonding Material for Ultra-Thin Semiconductor Wafers

  New bonding material enables thinner semiconductor wafers, enhancing AI, NAND, and power semiconductor performance while reducing environmental impact. Mass production set for 2028.
• 

  25 November 2025

  Toray Licenses Drug Candidate for Peripheral Neuropathy Treatment

  Sanodyne gains rights to develop TRK-750 for neuropathy. SNT-001 shows promise in trials, with Phase II planned. Collaboration aims to advance treatment options.